<DOC>
	<DOCNO>NCT00017797</DOCNO>
	<brief_summary>The purpose study find HIV-infected pregnant woman take protease inhibitor ( PIs ) likely blood sugar problem take PIs . HIV-infected people generally treat combination different type anti-HIV drug , 1 usually PI . The hold true pregnant woman , much know use drug pregnancy . Blood sugar liver problem cause anti-HIV drug nonpregnant patient well know effect pregnancy . Also , certain physical change bring pregnancy may affect way drug handle body . There remain need study use anti-HIV drug pregnancy effect safety mother baby .</brief_summary>
	<brief_title>Problems Associated With Use Anti-HIV Drugs HIV-Infected Pregnant Women</brief_title>
	<detailed_description>The dramatic impact potent combination antiretroviral therapy course HIV disease make use PIs routine care HIV-1-infected individual . Combination therapy likewise become standard care pregnant individual , even though information use drug human pregnancy limit . There publish prospective evaluation toxicity experience pregnant woman PI-containing antiretroviral regimen , despite finding metabolic disturbance glucose , fatty acid , cholesterol , well lactic acidosis/hepatic steatosis nonpregnant individual treat antiretrovirals . Gastrointestinal ( GI ) side effect also well document nonpregnant individual treat PIs , systematically evaluated pregnancy . In addition , physiologic change bring pregnancy may influence pharmacokinetics , safety , side effect antiretroviral drug . There remain need evaluation use antiretrovirals pregnancy impact maternal , fetal , infant safety . Patients stratify accord whether PI-containing antiretroviral regimen number week gestation ( 26 week less versus great 26 week ) . Patients follow 8-week interval time entry delivery pregnancy termination , additional visit 12 week delivery pregnancy termination . All infant bear study participant evaluate time delivery ( anthropometrics HIV DNA PCR ) see mother ' 12-week post-delivery visit . Glucose tolerance test metabolic study perform serially pregnancy postpartum . This observational study drug supply . Patients receive antiretroviral therapy must obtain medication .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are female 13 year age old . Are 20 34 week pregnant study entry . Had ultrasound perform 16 week pregnancy . Have consent parent guardian 18 year age . The father baby , available , also must give consent . Have take antiHIV drug , include PI , 8 week study entry . If take PI antiHIV drug , must take PI 8 week study entry . Patients must carry way entire study . Exclusion Criteria Patients eligible study : Have diabetes . Patients diabetes caused pancreas problem steroid use past , normal blood sugar without take drug special diet , allow . Patients blood sugar problem past pregnancy also allow . Had serious infection medical condition within 30 day study entry . Are enrol another study require lot blood test . Take , take 6 week study entry , follow drug : hormone ( growth hormone , testosterone , steroid ) , thalidomide , interleukin interferon , efavirenz , hydroxyurea , drug control blood sugar , anticancer drug . Take , take year study entry , steroid , e.g. , prednisone , 14 day 3month period . Inhaled steroid steroid creams/ointments allow . Take , take 30 day study entry , PIs lovastatin simvastatin ( 2 drug low amount fat blood ) . Have ultrasound showing major abnormality baby . Have problem pregnancy and/or expect 1 baby . Abuse drug alcohol .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Pregnancy Complications , Infectious</keyword>
	<keyword>HIV-1</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Glucose Intolerance</keyword>
</DOC>